{"entity":{"id":"nct04883814","kind":"trial","name":"18F-fluoroestradiol (FES) PET/CT for Breast Cancer","aka":[],"tldr":"A phase 2 trial of FES PET in Breast cancer, run by Hoag Memorial Hospital Presbyterian, with a status the registry has not verified recently.","summary":"18F-fluoroestradiol (FES) PET/CT for Breast Cancer is a phase 2 interventional study registered as NCT04883814 by Hoag Memorial Hospital Presbyterian, with 124 participants planned, started 2021-01-15 and due to reach its primary completion in 2023-12-15. Interventions recorded: 18F-fluoroestradiol PET/CT. Conditions recorded: Breast Cancer.\n\nLinked to the technology FES PET because the registry names it (\"18f fluoroestradiol pet\") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT04883814","url":"https://clinicaltrials.gov/study/NCT04883814"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["fes-pet"],"targets":[],"drugs":["fluoroestradiol-f18"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04883814","phase":"2","setting":"18F-fluoroestradiol (FES) PET/CT Compared To Standard-of-Care Imaging In Patients With Breast Cancer","sponsor":"Hoag Memorial Hospital Presbyterian","enrolled":124,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04883814/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"fes-pet","kind":"technology","name":"FES PET (oestrogen receptor imaging)","route":"/technologies/fes-pet/"}],"drug":[{"id":"fluoroestradiol-f18","kind":"drug","name":"Fluoroestradiol F-18 (FES PET)","route":"/drugs/fluoroestradiol-f18/"}]}}